Henry Ji
Tus Tuam Thawj, Thawj Tswj Hwm thiab CEO
- 25+ xyoo ntawm kev paub hauv biotechnology thiab life sciences kev lag luam
- Dr. Ji co-founded Sorrento thiab tau ua tus thawj coj txij li xyoo 2006, CEO thiab Thawj Tswj Hwm txij li xyoo 2012, thiab Thawj Tswj Hwm txij li xyoo 2017.
- Thaum nws ua haujlwm ntawm Sorrento, nws tau tsim kho thiab coj qhov kev loj hlob zoo ntawm Sorrento los ntawm kev tau txais thiab kev koom ua ke nrog rau Bioserv, Scilex Pharmaceuticals, Concortis Biotherapeutics, Levena Biopharma, LACEL, TNK Therapeutics, Virttu Biologics, Ark Tsiaj Lymphary Systems, thiab Sofury.
- Ua haujlwm raws li Sorrento Tus Thawj Saib Xyuas Kev Tshawb Fawb los ntawm 2008 txog 2012 thiab ua nws Tus Thawj Coj Ib ntus los ntawm 2011 txog 2012
- Ua ntej Sorrento, nws tau tuav cov thawj coj loj ntawm CombiMatrix, Stratagene thiab kuj tau koom nrog Stratagene Genomics, ib lub koom haum ntawm Stratagene, thiab tau ua nws Thawj Tswj Hwm & CEO thiab Thawj Tswj Hwm ntawm Pawg Thawj Coj.
- BS thiab Ph.D.
Kaw >
Mike Royal
Tus Thawj Saib Xyuas Kev Kho Mob
- Dr. Royal yog tus thawj coj ntawm kws tshuaj nrog 20 xyoo ntawm kev kho mob thiab kev kho mob. Tsis ntev los no, nws yog Tus Thawj Saib Xyuas Kev Kho Mob ntawm Suzhou Connect Biopharmaceuticals thiab, ua ntej ntawd, Concentric Analgesics. Nws rov koom nrog Sorrento qhov twg nws yav dhau los EVP, Kev Txhim Kho Kho Mob thiab Kev Tswj Xyuas Kev Tswj Xyuas hauv 2016
- Nws tau ua lub luag haujlwm rau lossis ua haujlwm hauv ntau NDAs ua tiav, suav nrog NCEs, 505(b)(2)s thiab ANDAs
- Dr. Royal yog pawg thawj coj saib xyuas kev noj qab haus huv, tshuaj kho mob, tshuaj loog nrog rau kev tsim nyog ntxiv hauv kev tswj qhov mob, tshuaj tiv thaiv thiab tshuaj raug cai.
- Nws tau ua Tus Kws Lij Choj Kws Kho Mob ntawm Uniformed Services University of Health Sciences, Assistant Professor of Anesthesiology/Critical Care Medicine ntawm University of Pittsburgh Medical Center, thiab tus kws tshaj lij ntawm University of Oklahoma thiab University of California San Diego
- Nws tau luam tawm ntau dua nrog ntau dua 190 phau ntawv tshooj, cov phooj ywg tshuaj xyuas cov ntawv thiab cov ntawv sau / cov ntawv tshaj tawm; thiab tau ua tus hais lus caw ntawm cov rooj sib tham hauv tebchaws thiab thoob ntiaj teb
- BS, MD, JD, MBA
Kaw >
Elizabeth Czerepak
Tus Lwm Thawj Coj Thawj Coj, Tus Thawj Saib Xyuas Nyiaj Txiag, Tus Thawj Saib Xyuas Kev Lag Luam
- 35+ xyoo ntawm kev paub txog nyiaj txiag thiab kev ua haujlwm hauv biotech thiab kws tshuaj
- Ms. Czerepak tau siv sijhawm 18 xyoo hauv Pharma loj thiab 11 xyoo ua CFO ntawm ntau yam biotechs, uas nws tau coj nyiaj txiag, koom tes thiab M&A kev siv zog. Pib nws txoj haujlwm ntawm Merck & Co., tau ua lub luag haujlwm tseem ceeb hauv Roche qhov $ 5.4B tau txais Syntex, thiab coj kev sib koom tes rau Humira® uas tau ua tiav hauv BASF Pharma qhov $ 6.8B muag rau Abbott.
- Rau cuaj xyoo ua Tus Thawj Coj ntawm JP Morgan thiab Bear Stearns, nws tau nrhiav tus khub dav dav ntawm $ 212M venture fund, qhov chaw uas nws tau coj kev nqis peev hauv 13 biotechs, ua haujlwm ntawm pawg thawj coj saib thiab pab txhawb kev tawm los ntawm IPO thiab tau txais. Series 7 thiab Series 63 FINRA (NASD) Registered Representative from 2001 to 2008.
- Cov tswvcuab uas muaj kev paub dhau los (xws li Sorrento thiab Scilex) thiab tus thawj coj saib xyuas, tau txais Daim Ntawv Pov Thawj Tus Thawj Coj los ntawm Harvard Business School hauv 2020.
- BA thiab MBA
Kaw >
Mark R. Brunswick
Senior Vice President Regulatory Affairs
- Dr. Brunswick muaj ntau tshaj 35 xyoo ntawm cov haujlwm laus hauv Kev Tswj Xyuas Kev Lag Luam suav nrog ntau dua 9 xyoo hauv US FDA, Center for Biologics, Division of Monoclonal Antibodies
- Ua ntej koom nrog Sorrento, Dr. Brunswick yog Tus Thawj Saib Xyuas Kev Tswj Xyuas Kev Tswj Xyuas thiab Kev Ua Haujlwm Zoo ntawm Sophiris Bio, lub tuam txhab tsim tshuaj rau benign prostatic hyperplasia thiab mob qog noj ntshav prostate. Ua ntej nws yog tus thawj coj ntawm Kev Tswj Xyuas Kev Ua Haujlwm ntawm Arena Pharmaceuticals tshwj xeeb hauv kev kho mob qhia ntawm G Protein receptors
- Dr. Brunswick coj pawg tswj hwm ntawm Elan Pharmaceuticals tsom rau Alzheimer Disease thiab mob compound, ziconotide
- BS thiab Ph.D.
Kaw >
Xiao Xu
Thawj Tswj Hwm ACEA
- Dr. Xu muaj ntau tshaj 20 xyoo dhau los ua tus thawj coj hauv biotech industries. Dr. Xu yog ib tug cofounder, tus thawj tswj hwm thiab CEO ntawm ACEA Biosciences (tau los ntawm Agilent hauv 2018) thiab ACEA Therapeutics (tau txais los ntawm Sorrento Therapeutics hauv 2021). Nws koom Sorrento Therapeutics tom qab tau txais, thiab tseem ua haujlwm ua Thawj Tswj Hwm ntawm ACEA, ib lub koom haum ntawm Sorrento Therapeutics.
- Nws tau tswj hwm thiab ua lub luag haujlwm rau ACEA txoj kev tsim kho cov kav dej, kev tshawb fawb soj ntsuam, thiab cGMP chaw tsim khoom.
- Nws yog tus neeg tsim khoom tshiab ntawm cov ntawv sau tshiab tsis muaj xov tooj ntawm tes-raws li kev soj ntsuam thev naus laus zis thiab lub luag haujlwm rau kev siv thev naus laus zis / khoom tsim kho thiab kev koom tes ua lag luam nrog Roche Diagnosis, kev lag luam thoob ntiaj teb ntawm ACEA cov cuab yeej cuab tam thiab cov khoom lag luam, thiab $ 250 lab Agilent tau txais ACEA Biosciences.
- Nws tau ua haujlwm tshawb nrhiav thiab tshawb fawb cov kws tshawb fawb ntawm Gladstone Institutes, Lub Tsev Haujlwm Tshawb Fawb Scripps thiab US Centers for Disease Control and Prevention. Nws muaj ntau tshaj 50 US patents thiab daim ntawv thov patent thiab tau luam tawm ntau tshaj 60 cov ntawv tshawb fawb hauv cov ntawv xov xwm thoob ntiaj teb, suav nrog Science, PNAS, Nature Biotechnology, thiab Chemistry thiab Biology.
- BS, MS, thiab MD
Kaw >
Shawn Saib
Senior Vice President Commercial Operations
- Dr. Sahebi coj Sorrento txoj haujlwm ua lag luam
- Nqa ntau tshaj 30 xyoo ntawm kev siv tshuaj nrog rau kev tshawb fawb txog kev lag luam thiab kev lag luam zoo rau Sorrento
- Ua ntej koom nrog Sorrento, nws tuav txoj haujlwm loj nrog Novartis, Pfizer, thiab Lilly txhim kho kev lag luam analytics thiab cov ntaub ntawv tsav tsheb cov tswv yim lag luam lub luag haujlwm rau kev muag khoom loj hlob ntawm ntau dua 20 cov khoom lag luam mus txog cov xwm txheej hauv cov hlab plawv, Mob caj dab, Neuroscience, Ntshav Qab Zib, thiab Oncology.
- Kev ntseeg ruaj khov tias cov kab lis kev cai sib koom ua ke tsim pab pawg yeej
- Yav dhau los Thawj Tswj Hwm, Pharmaceutical Management Science Association of America
- BA, MBA thiab Ph.D.
Kaw >
Brian Cooley
Senior Vice President, Corporate Communications thiab Lymphatic Drug Development BU
- 30+ xyoo ntawm kev paub hauv biopharmaceutical thiab life science kev lag luam
- Mr. Cooley tuav ntau yam kev muag khoom, kev lag luam, thiab kev coj noj coj ua hauv kev lag luam ntawm hmoov zoo 500 tuam txhab thiab tau ua tiav kev nce nyiaj thiab pib siv zog rau cov tuam txhab kho mob thev naus laus zis
- Ua ntej koom nrog Sorrento, Mr. Cooley tau coj thoob ntiaj teb kev tshaj tawm cov khoom lag luam tshiab tshaj tawm kev siv zog nrog P&L lub luag haujlwm ntawm Eli Lilly thiab tuam txhab thiab Genentech hauv cov kab mob xws li Ntshav Qab Zib, Neurology, Immunology thiab Kab Mob Tsis tshua muaj.
- Tsis tas li ntawd, nws kuj tau coj cov BD tseem ceeb, hauv daim ntawv tso cai, thiab kev sib koom ua ke kev sib koom ua ke thoob ntiaj teb thiab hauv Teb Chaws Asmeskas Qhov no suav nrog ntau yam kev lag luam nthuav dav hauv Europe, Middle East thiab Africa, thiab daim ntawv cog lus $ 400MM kev sib koom tes rau hauv daim ntawv tso cai, tsim thiab ua lag luam. thawj GLP-1 agonist
- Tsis ntev los no, Mr. Cooley yog CBO rau Sofusa Business Unit ntawm Kimberly-Clark thiab coj kev muag khoom zoo thiab kev sib koom ua ke rau hauv Sorrento Therapeutics. Nws tseem ua tus thawj coj hauv Lymphatic Drug Delivery systems faib ntawm Sorrento.
- BS
Kaw >
Bill Farley
Vice President Business Development
- 30+ xyoo ntawm kev paub hauv Kev Txhim Kho Kev Lag Luam, Kev Muag Khoom thiab kev coj ua hauv kev tshawb nrhiav tshuaj, kev txhim kho thiab kev koom tes
- Ua ntej koom nrog Sorrento, Mr. Farley tau tuav txoj haujlwm ua thawj coj ntawm HitGen, WuXi Apptec, VP ntawm Key Accounts lub tsev thiab ua tus pab pawg BD thoob ntiaj teb; ChemDiv, VP ntawm BD ntawm, ua ntau yam kev siv zog los tsim cov tuam txhab kho mob tshiab hauv CNS, Oncology thiab Anti-infectives
- Mr. Farley tau ua tus kws pab tswv yim rau ntau pab pawg tswj hwm thiab BODs los tsim thiab ua lag luam cov cuab tam nrog cov nyiam Xencor, Caliper Technologies thiab Stratagene.
- Nws tau tsim kom muaj kev sib koom tes zoo thoob plaws hauv cov tuam txhab tshuaj, biotech thiab Venture Capital zej zog. Mr. Farley tau hais lus ntawm ntau lub rooj sib tham thiab tau luam tawm ntau yam kev tshuaj xyuas cov phau ntawv sib tham
- BS
Kaw >
Alexis Nahama
Senior Vice Thawj Tswj Hwm Neurotherapeutics BU
- Dr. Nahama coj RTX human and animal health drug development programs
- Raws li ib tug tswv cuab ntawm pawg thawj coj, Dr. Nahama txhawb nqa kev tsim kho lub tswv yim, saib xyuas cov haujlwm muaj txiaj ntsig zoo, txhawb kev mus rau kev npaj ua lag luam, thiab txhawb nqa kev sib koom tes sab nraud.
- Kev mob siab rau tsav lub sijhawm kev txhais lus txhawm rau txhawm rau txhim kho tib neeg cov kev pab cuam thaum nqa cov thev naus laus zis uas txwv tsis pub muaj rau cov tsiaj
- Ua ntej koom nrog Sorrento, nws tau siv sijhawm ntau dua 25 xyoo tuav lub luag haujlwm thoob ntiaj teb ua haujlwm hauv Life Sciences thiab Biotechnology rau Sanofi, Colgate, Novartis, Merck, VCA Antech thiab VetStem Biopharma
- DVM nrog rau kev ua haujlwm thaum ntxov tsom rau R&D hauv thaj chaw mob (kev sim tshuaj rau tsiaj)
Kaw >
10bio mus here10: dangler l=5